These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33272096)

  • 21. Medication adherence and rejection rates in older vs younger adult liver transplant recipients.
    Leven EA; Annunziato R; Helcer J; Lieber SR; Knight CS; Wlodarkiewicz C; Soriano RP; Florman SS; Schiano TD; Shemesh E
    Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28370346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-reported immunosuppression nonadherence 6 to 24 months after liver transplant: association with pretransplant psychosocial factors and perceptions of health status change.
    Rodrigue JR; Nelson DR; Hanto DW; Reed AI; Curry MP
    Prog Transplant; 2013 Dec; 23(4):319-28. PubMed ID: 24311395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the stanford integrated psychosocial assessment for transplant for heart, liver, and kidney transplant candidates in Japan.
    Takano K; Oshibuchi H; Kobayashi S; Tsutsui J; Ito S; Kamba R; Akaho R; Nishimura K
    Biopsychosoc Med; 2023 Jul; 17(1):24. PubMed ID: 37461076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation.
    Deutsch-Link S; Weinrieb RM; Jones LS; Solga SF; Weinberg EM; Serper M
    Dig Dis Sci; 2020 Jul; 65(7):2089-2103. PubMed ID: 31707529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychosocial predictors of medication adherence in pediatric heart and lung organ transplantation.
    Killian MO
    Pediatr Transplant; 2017 Jun; 21(4):. PubMed ID: 28198130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of the Stanford Integrated Psychosocial Assessment for Transplant in predicting outcomes before and after lung transplantation.
    Westall GP; Barnes H; Levin K; Gaffney N; Harris J; Martinez O; Emsley C; Fuller L; Levvey B; Snell GI; Winton-Brown T
    J Heart Lung Transplant; 2024 Apr; 43(4):571-579. PubMed ID: 38000763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment and Treatment of Nonadherence in Transplant Recipients.
    Shneider C; Dunphy C; Shemesh E; Annunziato RA
    Gastroenterol Clin North Am; 2018 Dec; 47(4):939-948. PubMed ID: 30337042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients.
    Serper M; Patzer RE; Reese PP; Przytula K; Koval R; Ladner DP; Levitsky J; Abecassis MM; Wolf MS
    Liver Transpl; 2015 Jan; 21(1):22-8. PubMed ID: 25312406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication adherence in pediatric and adolescent liver transplant recipients.
    Shemesh E; Shneider BL; Savitzky JK; Arnott L; Gondolesi GE; Krieger NR; Kerkar N; Magid MS; Stuber ML; Schmeidler J; Yehuda R; Emre S
    Pediatrics; 2004 Apr; 113(4):825-32. PubMed ID: 15060234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No Apparent Influence of Nonadherence on Tacrolimus Intrapatient Variability in Stable Kidney Transplant Recipients.
    Gokoel SRM; Zwart TC; Moes DJAR; van der Boog PJM; de Fijter JW
    Ther Drug Monit; 2020 Oct; 42(5):702-709. PubMed ID: 32941396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression, Immunosuppressant Levels, and Clinical Outcomes in Postlung Transplant Recipients.
    Chu MC; Smith PJ; Reynolds JM; Palmer SM; Snyder LD; Gray AL; Blumenthal JA
    Int J Psychiatry Med; 2020 Nov; 55(6):421-436. PubMed ID: 32052665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demographic Factors, Medication Adherence, and Post-transplant Health Outcomes: A Longitudinal Multilevel Modeling Approach.
    Killian MO; Little CW; Howry SK; Watkivs M; Triplett KN; Desai DM
    J Clin Psychol Med Settings; 2024 Mar; 31(1):163-173. PubMed ID: 37589865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients.
    Sankaranarayanan J; Collier D; Furasek A; Reardon T; Smith LM; McCartan M; Langnas AN
    Res Social Adm Pharm; 2012; 8(3):228-39. PubMed ID: 21856247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the SIPAT instrument to assess psychosocial risk in heart transplant candidates: A retrospective single center study.
    Vandenbogaart E; Doering L; Chen B; Saltzman A; Chaker T; Creaser JW; Rourke D; Cheng RW; Fonarow GC; Deng M
    Heart Lung; 2017; 46(4):273-279. PubMed ID: 28527833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing medication adherence in solid-organ transplant recipients.
    Su GC; Greanya ED; Partovi N; Yoshida EM; Shapiro RJ; Levy RD
    Exp Clin Transplant; 2013 Dec; 11(6):475-81. PubMed ID: 24344939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the Stanford Integrated Psychosocial Assessment for Transplant and 1-Year Outcome of Living Kidney Transplantation in Japan.
    Takano K; Kobayashi S; Oshibuchi H; Tsutsui J; Mishima N; Ito S; Kamba R; Akaho R; Nishimura K
    J Acad Consult Liaison Psychiatry; 2024; 65(1):14-24. PubMed ID: 37778460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening.
    Dobbels F; Vanhaecke J; Dupont L; Nevens F; Verleden G; Pirenne J; De Geest S
    Transplantation; 2009 May; 87(10):1497-504. PubMed ID: 19461486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence.
    Pizzo HP; Ettenger RB; Gjertson DW; Reed EF; Zhang J; Gritsch HA; Tsai EW
    Pediatr Nephrol; 2016 Dec; 31(12):2345-2352. PubMed ID: 27286686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial.
    Han A; Min SI; Ahn S; Min SK; Hong HJ; Han N; Kim YS; Ahn C; Ha J
    PLoS One; 2019; 14(11):e0224595. PubMed ID: 31689320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the Stanford Integrated Psychosocial Assessment for Transplant (SIPAT) in Lung Transplant Candidates.
    Chernyak Y; Henderson DR; Teh L; Powell AL; Hinton KE; Hage CA
    J Clin Psychol Med Settings; 2022 Mar; 29(1):137-149. PubMed ID: 34043137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.